Afatinib CAS 439081-18-2 Kemurnian >99,5% (HPLC) Pabrik
Ruifu Chemical Supply Intermediates saka Afatinib
Afatinib CAS 439081-18-2
Afatinib Dimaleate CAS 850140-73-7
(S)-(+)-3-Hydroxytetrahydrofuran CAS 86087-23-2
(Dimethylamino)acetaldehyde Diethyl Acetal CAS 3616-56-6
trans-4-Dimethylaminocrotonic Acid Hydrochloride CAS 848133-35-7
Asam Dietilphosphonoacetic CAS 3095-95-2
7-Fluoro-6-Nitroquinazolin-4(1H)-siji CAS 162012-69-3
7-Chloro-6-Nitro-4-Hydroxyquinazoline CAS 53449-14-2
N-(3-Chloro-4-Fluorophenyl)-7-Fluoro-6-Nitroquinazolin-4-Amine CAS 162012-67-1
(S)-N4-(3-Chloro-4-Fluorophenyl)-7-((Tetrahydrofuran-3-yl)oxy)quinazoline-4,6-DiamineCAS 314771-76-1
(S)-N-(3-Chloro-4-Fluorophenyl)-6-Nitro-7-((Tetrahydrofuran-3-yl)oxy)quinazolin-4-AmineCAS 314771-88-5
Jeneng Kimia | Afatinib |
sinonim | BIBW2992;BIBW-2992;BIBW2992 Free Base;Tomtovok;(S,E)-N-(4-(3-Chloro-4-Fluorophenylamino)-7-(Tetrahydrofuran-3-yloxy)quinazolin-6-yl)-4-(Dimethylamino)nanging-2-Enamide |
Nomer CAS | 439081-18-2 |
Nomer CAT | RF-PI2033 |
Status Simpenan | Ing Simpenan, Skala Produksi Nganti Ton |
Formula Molekul | C24H25ClFN5O3 |
Bobot Molekul | 485.94 |
Kelarutan | Larut ing DMSO |
Kapadhetan | 1.380 |
Merk | Kimia Ruifu |
Item | Spesifikasi |
Penampilan | Wêdakakêna Putih |
Identifikasi | HPLC, NMR |
Kemurnian / Metode Analisis | > 99,5% (HPLC) |
Titik Lebur | 100,0 ~ 102,0 ℃ |
Mundhut ing Pangatusan | <0,50% |
Sisa ing Ignition | <0,20% |
Total Impurities | <0,50% |
Logam abot | ≤20ppm |
Spektrum NMR | Conforms kanggo Struktur |
Test Standar | Standar Perusahaan |
Urip beting | 24 Wulan yen disimpen kanthi bener |
Panggunaan | API;Afatinib;Afatinib Dimaleate;NSCLC |
Paket: Botol, tas Aluminium foil, 25kg / Karton Drum, utawa miturut kabutuhan pelanggan
Kondisi panyimpenan:Simpen ing wadhah sing disegel ing papan sing adhem lan garing;Nglindhungi saka cahya lan Kelembapan
Afatinib, uga dikenal minangka BIW-2992, (CAS: 439081-18-2) minangka inhibitor ganda sing kuat lan ora bisa dibatalake generasi kaping pindho saka reseptor faktor pertumbuhan epidermal (EGFR) lan reseptor faktor pertumbuhan epidermis manungsa 2 (HER2) tyrosine kinase, dikembangake dening Boehringer Ingelheim, Jerman.Iki bisa nyegah aktivitas tyrosine kinase kanthi ora bisa dibatalake kanthi ngalami reaksi Michael karo gugus tiol sistein ing posisi 797 EGFR.Tanggal 12 Juli 2013, obat kasebut dadi obat anyar kanggo kanker paru-paru sel cilik sing disetujoni dening FDA AS kanthi jeneng dagang Gilotrif.Obat iki minangka tablet.Iki digunakake kanggo perawatan pasien sing didiagnosis kanker paru-paru sel non-small metastatik (NSCLC) kanthi mundhut mutasi exon kaping 19 utawa L858R ing ekson kaping 21 saka reseptor faktor pertumbuhan epidermis tumor (EGFR) dikonfirmasi nggunakake kit sing disetujoni. dening FDA.Obat kasebut uga efektif kanggo perawatan pasien positif HER2 kanthi kanker payudara lanjut.Afatinib kalebu kelas obat sing dikenal minangka inhibitor tyrosine kinase.Inhibitor tirosin kinase dirancang kanggo ngalangi aksi enzim tartamtu sing diarani tyrosine kinase.Enzim iki nduweni peran gedhe ing fungsi sel, lan aktif ningkatake pertumbuhan lan perkembangan tumor.Afatinib kerjane kanggo nyandhet fungsi rong jinis kinase tirosin: reseptor faktor pertumbuhan epidermis (EGFR) lan Her2, sing "diekspresikake" dening sawetara jinis kanker.Kanthi ngalangi fungsi kinase tyrosine iki, Afatinib bisa nyegah sel kanker saka pamisah lan tuwuh.